Influence of RAS polymorphisms on the development and perinatal outcome of preeclampsia. Genetic RAS evaluation

Gineco.ro

Volumn 5, Issue 2, 2009, Pages 88-93

  Procopciuc, Lucia Maria ^a   Caracostea, Gabriela ^a   Iordache, Georgiana ^a   Olteanu, Ileana ^a   Stamatian, F ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

PCR RFLP methods; Perinatal outcome; Preeclampsia; RAS polymorphisms

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; METHIONINE; RENIN; THREONINE;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HUMAN; INDEL MUTATION; PREECLAMPSIA; PREGNANCY OUTCOME; SYSTOLIC BLOOD PRESSURE;

EID: 79955837433     PISSN: 18414435     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Reynolds C., et al. "Hypertensive States of Pregnancy" In: A.H. DeCherney, L. Nathan: Current Obstetric & Gynecologic Diagnosis & Treatment- 5 th Edition, Ed. New York: McGraw Hill Co 2003.
2. Nilsson E., Salonen Ros H., Cnattingius S. and Lichtenstein P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 2004; 111: 200-206. (Pubitemid 38299582)
3. Carr D.B., Epplein M., Johnson C.O., Easterling T.R. and Critchlow C.W. A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 2005; 193: 965-972. (Pubitemid 41285478)
4. Haukkamaa L., Salminen M., Laivuori H., Leinonen H., Hiilesmaa V., Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004; 93: 805-808 (Pubitemid 38338587)
5. John M. D., Volker H., Arun J., Kirk P. C., S. Ananth K., Susan Q.|, Dechend R. and Luft F.C. New Aspects in the Pathophysiology of Preeclampsia. J Am Soc Nephrol 2004; 15: 2440-2448.
6. Baha M. Sibai. Maternal and Uteroplacental Hemodynamics for the Classification and Prediction of Preeclampsia. Hypertension 2008; 52: 805.
7. Morgan T., Craven C., Ward K. Human spiral artery renin-angiotensin system. Hypertension 1998; 32: 683-687. (Pubitemid 28480544)
8. van Dijk M., Mulders J., Poutsma A., Konst A.A., Lachmeijer A.M., Dekker G.A., Blankenstein M.A. and Oudejans C.B. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 2005; 37: 514-519. (Pubitemid 40617280)
9. Moses E.K., Fitzpatrick E., Freed K.A., Dyer T.D., Forrest S., Elliott K., Johnson M.P., Blangero J. and Brennecke S.P. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 2006; 12: 505-512 (Pubitemid 44288196)
10. Laskowska M., Leszczynska-Gorzelak B., Laskowska K., Oleszczuk J. Evaluation of the renin-angiotensin-aldosterone system in pregnancy complicated by preeclampsia with and without intrauterine growth retardation. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 2004; 59(2): 451-6.
11. Roberts J.M., Lain K.Y. Recent Insights into the pathogenesis of preeclampsia. Placenta 2002; 23: 359-72.
12. Russ A. P., Maerz, W., Ruzicka, V., Stein, U. & Gross, W. Rapid detection of the hypertension-associated Met235->Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2: 609-610. (Pubitemid 23140035)
13. Caulfield M., Lavender P., Farral M. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med 1994; 330: 1629
14. Evans A. E., Poirier O., Kee F., Lecerf L. E. M., Falconer T., Crane J., O'Rourke D. F. & Cambien F. C- University College London 2003 Annals of Human Genetics 2003; 67: 17-25.
15. Frossard P. M., Lestringant G. G., Elshahat Y. I., John A. & Obineche E. N. An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. Hypertens Res 1998; 21: 221-225.
16. Takemoto Y., Sakatani M., Takami S., Tachibana T., Higaki J., Ogihara T. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax 1998; 53: 459-462. (Pubitemid 28308060)
17. Skjærven R., Vatten L.J., Wilcox A.J., Rønning T., Irgens L.M. and Terje Lie R. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005; 331: 877.
18. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.M., Corvol P. Molecular basis of human hypertension: role of angiotensinogen Cell 1992; 71: 169-80.
19. Levesque J., et al. Implication of an AGT Haplotype in a Multigene Association Study With Pregnancy Hypertension. Hypertension 2004; 43: 1-8.
20. Hyunah C., Kang J.Y., Yoon H.S., Han S.S., Whang C.S., In Gul Moon*, Hyun-Ho Shin, Jeong Bae Park. J Korean Med Sci. Association of Angiotensin-Converting Enzyme and Angiotensinogen Gene Polymorphisms with Preeclampsia 2004; 19: 253-7
21. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. Am J Hum Genet 1992; 51:197-205.
22. Choi H., Kang J.Y., Yoon H.S., Han S.S., Whang C.S., Moon I.G., Shin H.H., Park J.B. Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci. 2004;19(2): 253-7. (Pubitemid 38591800)
23. Morgan T., Craven C., Lalouel J.M., Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180: 95-102 (Pubitemid 29088396)
24. Kaur R., Jain V., Khuller M., Gupta I., Sherawat B.S. Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2005; 84: 929-933. (Pubitemid 41400291)
25. Roh C.R., Kim D.K., Yoon B.K., Yang S.H., Chung J.H., Bae D.S., Lee J.H. A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders. Korean J Obstet Gynecol 1997; 40: 1189-99.
26. Kurtz T.W., Simonet L., Kabra P.M., Wolfe S., Chan L., Hjelle B.L. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest 1990; 85(4):1328-32 (Pubitemid 20123782)
27. Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension Hypertension 1994 ; 24(1):63-9.
28. Bouba I., Makrydimas G., Kalaitzidis R., Lolis D.E., Siamopoulos K.C., Georgiou L. Interaction between the polymorphisms of the rennin- angiotensin system in preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2003; 110: 8-11. (Pubitemid 37025689)
29. World Health Organization Chapter 2; Making pregnancy safer. Biennial report UNCP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. World Health Organization, Geneva, Switzerland, 2002; pp. 25-30.
30. Mello G., Parretti E., Gensini F., Sticchi E., Mecacci F., Scarselli G., Genuardi M., Abbate R., Fatini C. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41: 932-7. (Pubitemid 36418468)